BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maes M, Moraes JB, Bonifacio KL, Barbosa DS, Vargas HO, Michelin AP, Nunes SOV. Towards a new model and classification of mood disorders based on risk resilience, neuro-affective toxicity, staging, and phenome features using the nomothetic network psychiatry approach. Metab Brain Dis 2021;36:509-21. [PMID: 33411213 DOI: 10.1007/s11011-020-00656-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 30.0] [Reference Citation Analysis]
Number Citing Articles
1 Al-Hakeim HK, Al-Rubaye HT, Al-Hadrawi DS, Almulla AF, Maes M. Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: a proof of concept and mechanism study. Mol Psychiatry 2022. [PMID: 36280755 DOI: 10.1038/s41380-022-01836-9] [Reference Citation Analysis]
2 Almulla AF, Thipakorn Y, Vasupanrajit A, Tunvirachaisakul C, Oxenkrug G, Al-Hakeim HK, Maes M. The Tryptophan Catabolite or Kynurenine Pathway in a Major Depressive Episode with Melancholia, Psychotic Features and Suicidal Behaviors: A Systematic Review and Meta-Analysis. Cells 2022;11:3112. [PMID: 36231075 DOI: 10.3390/cells11193112] [Reference Citation Analysis]
3 Maes M, Moraes JB, Congio A, Vargas HO, Nunes SOV. Research and Diagnostic Algorithmic Rules (RADAR) for mood disorders, recurrence of illness, suicidal behaviors, and the patient’s lifetime trajectory.. [DOI: 10.1101/2022.09.15.22279968] [Reference Citation Analysis]
4 Maes M, Al-Rubaye HT, Almulla AF, Al-Hadrawi DS, Stoyanova K, Kubera M, Al-Hakeim HK. Lowered Quality of Life in Long COVID Is Predicted by Affective Symptoms, Chronic Fatigue Syndrome, Inflammation and Neuroimmunotoxic Pathways. Int J Environ Res Public Health 2022;19:10362. [PMID: 36011997 DOI: 10.3390/ijerph191610362] [Reference Citation Analysis]
5 Almulla AF, Thipakorn Y, Vasupanrajit A, Tunvirachaisakul C, Oxenkrug G, Al-hakeim HK, Maes M. The tryptophan catabolite or kynurenine pathway in a major depressive episode with melancholia, psychotic features and suicidal behaviors; a systematic review and meta-analysis.. [DOI: 10.1101/2022.08.06.22278492] [Reference Citation Analysis]
6 Maes M, Al-rubaye HT, Almulla AF, Al-hadrawi DS, Stoyanova K, Kubera M, Al-hakeim HK. Lowered quality of life in Long COVID is strongly predicted by affective symptoms and chronic fatigue syndrome which are associated with inflammatory processes during the acute infectious phase and consequent neuroimmunotoxic pathways.. [DOI: 10.1101/2022.07.25.22277980] [Reference Citation Analysis]
7 Al-hakeim HK, Al-naqeeb TH, Almulla AF, Maes M. The physio-affective phenome of major depression is strongly associated with biomarkers of astroglial and neuronal projection toxicity which in turn are associated with peripheral inflammation, insulin resistance and lowered calcium.. [DOI: 10.1101/2022.07.04.22277246] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Maes MH, Stoyanov D. False dogmas in mood disorders research: Towards a nomothetic network approach. World J Psychiatry 2022; 12(5): 651-667 [DOI: 10.5498/wjp.v12.i5.651] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
9 Maes M, Rachayon M, Jirakran K, Sodsai P, Klinchanhom S, Debnath M, Basta-kaim A, Kubera M, Almulla AF, Sughondhabirom A. Adverse Childhood Experiences Predict the Phenome of Affective Disorders and These Effects Are Mediated by Staging, Neuroimmunotoxic and Growth Factor Profiles. Cells 2022;11:1564. [DOI: 10.3390/cells11091564] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
10 Al-hakeim HK, Al-rubaye HT, Al-hadrawi DS, Almulla AF, Maes M. Long-COVID post-viral chronic fatigue syndrome and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: a proof of concept and mechanism study.. [DOI: 10.1101/2022.04.25.22274251] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Maes M, Barbosa DS, Almulla AF, Kanchanatawan B. A Novel Pathway Phenotype of Temporal Lobe Epilepsy and Comorbid Psychiatric Disorders: Results of Precision Nomothetic Medicine. Antioxidants 2022;11:803. [DOI: 10.3390/antiox11050803] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
12 Maes M, Rachayon M, Jirakran K, Sodsai P, Klinchanhom S, Gałecki P, Sughondhabirom A, Basta-kaim A. The Immune Profile of Major Dysmood Disorder: Proof of Concept and Mechanism Using the Precision Nomothetic Psychiatry Approach. Cells 2022;11:1183. [DOI: 10.3390/cells11071183] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
13 Maes M. Precision Nomothetic Medicine in Depression Research: A New Depression Model, and New Endophenotype Classes and Pathway Phenotypes, and A Digital Self. JPM 2022;12:403. [DOI: 10.3390/jpm12030403] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
14 Maes M, Rachayon M, Jirakran K, Sodsai P, Klinchanhom S, Gałecki P, Sughondhabirom A. The immune profile of Major Dysmood Disorder: proof of concept and mechanism using the precision nomothetic psychiatry approach.. [DOI: 10.1101/2022.02.22.22271319] [Reference Citation Analysis]
15 Duarte-Silva E, Oriá AC, Mendonça IP, de Melo MG, Paiva IHR, Maes M, Joca SRL, Peixoto CA. TINY IN SIZE, BIG IN IMPACT: EXTRACELLULAR VESICLES AS MODULATORS OF MOOD, ANXIETY AND NEURODEVELOPMENTAL DISORDERS. Neurosci Biobehav Rev 2022;:104582. [PMID: 35182538 DOI: 10.1016/j.neubiorev.2022.104582] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Maes M, Barbosa DS, Kanchanatawan B. A novel pathway phenotype of temporal lobe epilepsy and comorbid psychiatric disorders: results of precision nomothetic medicine.. [DOI: 10.1101/2022.02.07.22270647] [Reference Citation Analysis]
17 Rachayon M, Jirakran K, Sodsai P, Klinchanhom S, Sughondhabirom A, Plaimas K, Suratanee A, Maes M. Effects of cannabidiol on activated immune-inflammatory pathways in major depressive patients and healthy controls.. [DOI: 10.1101/2022.02.04.22270489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Vasupanrajit A, Jirakran K, Tunvirachaisakul C, Solmi M, Maes M. Inflammation and nitro-oxidative stress in current suicidal attempts and current suicidal ideation: a systematic review and meta-analysis. Mol Psychiatry 2022. [PMID: 34997194 DOI: 10.1038/s41380-021-01407-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 14.0] [Reference Citation Analysis]
19 Al-Hakeim HK, Hadi HH, Jawad GA, Maes M. Intersections between Copper, β-Arrestin-1, Calcium, FBXW7, CD17, Insulin Resistance and Atherogenicity Mediate Depression and Anxiety Due to Type 2 Diabetes Mellitus: A Nomothetic Network Approach. J Pers Med 2022;12:23. [PMID: 35055338 DOI: 10.3390/jpm12010023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
20 Vasupanrajit A, Jirakran K, Tunvirachaisakul C, Maes M. Suicide attempts are associated with activated immune-inflammatory, nitro-oxidative, and neurotoxic pathways: A systematic review and meta-analysis. J Affect Disord 2021;295:80-92. [PMID: 34416621 DOI: 10.1016/j.jad.2021.08.015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 20.0] [Reference Citation Analysis]
21 Miola A, Dal Porto V, Tadmor T, Croatto G, Scocco P, Manchia M, Carvalho AF, Maes M, Vieta E, Sambataro F, Solmi M. Increased C-reactive protein concentration and suicidal behavior in people with psychiatric disorders: A systematic review and meta-analysis. Acta Psychiatr Scand 2021;144:537-52. [PMID: 34292580 DOI: 10.1111/acps.13351] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
22 Abe Y, Sirichokchatchawan W, Sangkomkamhang U, Satthapisit S, Maes M. Adverse childhood experiences combined with emotional and physical abuse by the partner predict antenatal depression. J Affect Disord 2021;298:194-201. [PMID: 34715193 DOI: 10.1016/j.jad.2021.10.099] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
23 Vasupanrajit A, Jirakran K, Tunvirachaisakul C, Solmi M, Maes M. Inflammation and nitro-oxidative stress in current suicidal attempts and current suicidal ideation: a systematic review and meta-analysis.. [DOI: 10.1101/2021.09.09.21263363] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Morelli NR, Maes M, Bonifacio KL, Vargas HO, Nunes SOV, Barbosa DS. Increased nitro-oxidative toxicity in association with metabolic syndrome, atherogenicity and insulin resistance in patients with affective disorders. J Affect Disord 2021;294:410-9. [PMID: 34320448 DOI: 10.1016/j.jad.2021.07.057] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
25 Maes M, Tangwongchai S. Mild cognitive impairment is not a valid concept and should be replaced by a more restrictive, biologically validated class, named Mild Cognitive Dysfunctions (MCD): a nomothetic network approach.. [DOI: 10.1101/2021.06.20.21259193] [Reference Citation Analysis]
26 Mousa RF, Smesam HN, Qazmooz HA, Al-Hakeim HK, Maes M. A pathway phenotype linking metabolic, immune, oxidative, and opioid pathways with comorbid depression, atherosclerosis, and unstable angina. CNS Spectr 2021;:1-15. [PMID: 34039448 DOI: 10.1017/S1092852921000432] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
27 Al-hakeim HK, Hadi HH, Jawad GA, Maes M. Intersections between copper, β-arrestin-1, calcium, FBXW7, CD17, insulin resistance and atherogenicity mediate depression and anxiety due to type 2 diabetes mellitus: a nomothetic network approach.. [DOI: 10.1101/2021.05.19.21257449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Maes M, Andrés-rodríguez L, Vojdani A, Sirivichayakul S, Barbosa DS, Kanchanatawan B. In schizophrenia, chronic fatigue syndrome- and fibromyalgia-like symptoms are driven by breakdown of the paracellular pathway with increased zonulin and immune activation-associated neurotoxicity.. [DOI: 10.1101/2021.05.09.21256897] [Reference Citation Analysis]
29 Vasupanrajit A, Jirakarn K, Tunvirachaisakul C, Maes M. Increased neurotoxicity due to activated immune-inflammatory and nitro-oxidative stress pathways in patients with suicide attempts: a systematic review and meta-analysis.. [DOI: 10.1101/2021.04.16.21255605] [Reference Citation Analysis]
30 Maes M, Kanchanatawan B. In (deficit) schizophrenia, a general cognitive decline partly mediates the effects of neuro-immune and neuro-oxidative toxicity on the symptomatome and quality of life. CNS Spectr 2021;:1-10. [PMID: 33843548 DOI: 10.1017/S1092852921000419] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
31 Maes M, Kanchanatawan B. In (deficit) schizophrenia, a general cognitive decline (G-CoDe) partly mediates the effects of neuro-immune and neuro-oxidative toxicity on the symptomatome and quality of life.. [DOI: 10.1101/2021.03.29.21254523] [Reference Citation Analysis]
32 Morris G, Puri BK, Bortolasci CC, Carvalho A, Berk M, Walder K, Moreira EG, Maes M. The role of high-density lipoprotein cholesterol, apolipoprotein A and paraoxonase-1 in the pathophysiology of neuroprogressive disorders. Neurosci Biobehav Rev 2021;125:244-63. [PMID: 33657433 DOI: 10.1016/j.neubiorev.2021.02.037] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
33 Stoyanov D, Maes MH. How to construct neuroscience-informed psychiatric classification? Towards nomothetic networks psychiatry. World J Psychiatr 2021; 11(1): 1-12 [PMID: 33511042 DOI: 10.5498/wjp.v11.i1.1] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 30] [Article Influence: 30.0] [Reference Citation Analysis]